The obligate mutualist: customer concentration as coevolution
Biology calls it obligate mutualism. Business calls it your best client. Both can end you.
Read →
Bioicus LAB
Bioicus LAB
Life sciences doesn't need more analysis. It needs someone who makes it happen and sell.
Ready to go to market?
Execution with scientific rigour and commercial intent. Not just advice.
You have the science, the team, and the ambition. What's often missing is the commercial infrastructure: a roadmap, a go-to-market logic, someone who connects R&D decisions to market outcomes and executes them directly.
Technology evaluation, IP landscape analysis, competitive positioning and white space identification. Intelligence that tells you where to move and how to move fast.
You have a compound with potential but no clear path to market. Licensing, spin-out, co-development: the options exist but the logic to choose between them rarely does. I help you map the commercial landscape and build the case that moves the right conversation forward.
Biology calls it obligate mutualism. Business calls it your best client. Both can end you.
Read →
Having a great scientific idea that doesn't stick with the market? The problem is rarely in the lab.
Read →
Transformation is the result of endless incremental steps. This matrix helps you see where you are.
Read →Strategic Product Leader
Stalled decisions become launches. That's what I do.
Serving life science companies across EMEA and LATAM markets.
My Bio →